imidazole has been researched along with Sarcoma in 1 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Alternative dosing regimens and combination with other targeted agents are needed to achieve successful development of nutlin in the clinical setting." | 1.42 | Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin. ( Chaire, V; Chibon, F; Coindre, JM; Hostein, I; Italiano, A; Lagarde, P; Laroche, A; Lesluyes, T; Lucchesi, C; Neuville, A; Tran-Cong, K, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Laroche, A | 1 |
| Tran-Cong, K | 1 |
| Chaire, V | 1 |
| Lagarde, P | 1 |
| Hostein, I | 1 |
| Coindre, JM | 1 |
| Chibon, F | 1 |
| Neuville, A | 1 |
| Lesluyes, T | 1 |
| Lucchesi, C | 1 |
| Italiano, A | 1 |
1 other study available for imidazole and Sarcoma
| Article | Year |
|---|---|
Heterogeneous Mechanisms of Secondary Resistance and Clonal Selection in Sarcoma during Treatment with Nutlin.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Prolifer | 2015 |